Formulary Approval
Every drip on your menu approved by name — Core Blends, NAD+, methylene blue and ketamine included — with additives, limits and required pre-treatment screening specified.
Clinic, mobile and event-based IV therapy all count as medical treatment — and the catalog runs wider than a Myers’ Cocktail. NAD+, methylene blue and ketamine each carry their own screening and administration rules on top of the general delegation question.
Each of these is a decision your director owns, in writing, before it happens in your clinic.
Every drip on your menu approved by name — Core Blends, NAD+, methylene blue and ketamine included — with additives, limits and required pre-treatment screening specified.
Who may place a line and administer, defined against your state’s rules.
Mobile and event work covered explicitly, including what has to travel with the team.
Reaction protocols and escalation, trained and documented per provider.
IV programs need formulary control, delegation that matches your staffing, and rules for treating outside the clinic walls — with extra screening wherever the drip is not a straightforward electrolyte bag.
Standing orders per drip formula and additive, including Core Blends, NAD+ and methylene blue
Delegation terms for RNs and other staff
Clearance screening policy, including telehealth where permitted
NAD+ titration protocol — infusion and subcutaneous, dosed to tolerance rather than a fixed ladder
Methylene blue screening for serotonergic medication use and G6PD deficiency before administration
Ketamine confined to in-clinic, physician-administered dosing, with no telehealth initiation or take-home pathway
Mobile and event protocols, including emergency response
Sterility, compounding and storage handling rules
Consent and adverse-reaction documentation
Still not sure? Twenty minutes on the phone answers what a page can't.
Yes — the treatment is medical wherever it happens. Off-site work usually needs additional protocol language, which we draft.
Often, under standing orders and supervision terms permitted by your state. Presence requirements vary and we confirm yours.
In some states, for some services. Your protocols encode the answer for the state you treat in.
Where your protocols include it, yes — but only in-clinic, physician-administered, with no telehealth initiation and no take-home pathway. That boundary does not move by location or state.
Can a non-physician own an IV therapy business? The storefront, the van and the brand, yes — the entity that orders and administers the infusion, generally no. IV therapy is medical treatment wherever it is delivered.
That is what the corporate practice of medicine doctrine decides — and it is the single rule that shapes how your business is built. Most states hold that medical judgment belongs to licensed clinicians, so a non-physician or a general corporation may not own or control an entity that practices medicine. The MSO model is the answer the industry settled on.
A doctrine in state law, not a company or a service. The professional entity — the PC — must be owned by a licensed physician, and control counts as much as ownership: who hires the clinicians, who sets the fees, who decides what gets treated.
The company that provides everything a IV Therapy clinic needs that is not the practice of medicine, under a written management services agreement with the PC. You can own the MSO outright, whatever your license.
How the two meet: a physician-owned PC employs the clinical team and holds the medical decisions; your MSO holds the brand, the lease, the staff, the systems and the supply; a fair-market management fee moves between them; and the line is drawn in writing where your state says it must be. Mobile and event-based operations do not change the answer; if anything they widen the exposure.
How money actually moves through a PC/MSO structure — patient revenue landing in the PC, the fixed management transfer to the MSO, MedGrid's retainer, and physician compensation — the same CPOM flow of funds covered on this page, walked through step by step.
This isn't just how we recommend running the accounts. In a state that enforces corporate practice of medicine, this exact flow is required to keep a PC structure compliant: revenue lands in the PC first, the MSO is paid a fixed, fair-market amount rather than a share of medical revenue, MedGrid is paid a fixed retainer by the MSO, and the accounts stay separate.
It's also why MedGrid only builds on a PC — never a PLLC — in every state we work in. A PLLC lets revenue flow straight into a member's account with no equivalent separation, which is exactly the structure this flow of funds is built to avoid. Why that distinction matters.
These are the arrangements we most often find in place when a clinic comes to us, usually built in good faith, on advice from someone who had not read the state's rules.
The clinical entity was formed as a plain LLC owned by a non-physician. In a strict state that is the whole problem, and it usually surfaces at diligence or renewal.
A physician agreed to "be the medical director" with no management agreement, no delegation document and no standing orders. There is nothing to show a board.
The MSO takes a percentage of clinical revenue. Many states read that as fee-splitting regardless of what the contract calls it.
Treatment protocols copied from a training weekend, never adapted to this state or signed by the director who is supposed to own them.
General information about how these structures work, not legal advice for your clinic. Your director and your counsel confirm the specifics before you treat.
Twenty minutes tells you what direction costs in your state, what has to be on file before the first patient, and how fast you can start.